首页> 美国卫生研究院文献>other >Cytoreduction for Colorectal Metastases: Liver Lung Peritoneum Lymph Nodes Bone Brain. When Does it Palliate Prolong Survival and Potentially Cure?
【2h】

Cytoreduction for Colorectal Metastases: Liver Lung Peritoneum Lymph Nodes Bone Brain. When Does it Palliate Prolong Survival and Potentially Cure?

机译:大肠转移的细胞减少:肝肺腹膜淋巴结骨脑。什么时候可以缓解延长生存期并可能治愈?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Colorectal cancer commonly metastasizes. The liver is the most frequent site of metastases and dominates the length of survival for this disease. As surgical and systemic therapies have become accepted and now are proven to be potentially curative, other sites of metastases have become more clinically relevant in terms of clinical symptoms and influence on survival. Treatment of extrahepatic metastases by surgical and ablative procedures is increasingly accepted and is proving to be effective at palliating symptoms, as well as life prolonging. In this review, we will first summarize key issues with metastatic colorectal cancer to the liver and available treatments. We will then discuss surgical and ablative treatments of other sites of disease including lung, lymph nodes, peritoneum, bone, and brain. Best available evidence for treatment strategies will be presented as well as potential new directions.
机译:大肠癌通常转移。肝脏是最常见的转移部位,并决定了该病的生存时间。随着外科手术和全身疗法被接受,并且现在被证明具有潜在的治疗作用,就临床症状和对生存的影响而言,其他转移灶在临床上也越来越相关。通过外科手术和消融手术治疗肝外转移已被越来越多地接受,并被证明可有效减轻症状和延长寿命。在这篇综述中,我们将首先总结肝脏转移性大肠癌的关键问题和可用的治疗方法。然后,我们将讨论其他疾病部位的外科手术和消融治疗,包括肺,淋巴结,腹膜,骨骼和大脑。将介绍治疗策略的最佳可用证据以及潜在的新方向。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号